Manalo, Babyn A.
HRN: 13-90-14 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
CEFUROXIME 1.5GM (VIAL)
07/15/2022
07/22/2022
IV
1.5g
Q8
LTCS
Waiting Final Action
07/16/2022
CEFUROXIME 500MG (TAB)
07/16/2022
07/23/2022
ORAL
500mg
BID
S/P CS
Waiting Final Action